BACKGROUND: Diabetes may be associated with differential outcomes in patients
undergoing left main coronary revascularization with percutaneous coronary intervention …

Background The Emory Angioplasty Versus Surgery Trial (EAST) is a randomized trial that
compares, by intention to treat, the clinical outcome and costs of percutaneous transluminal …

Objectives. This study sought to determine whether pravastatin affects clinical or
angiographic restenosis after coronary balloon angioplasty. Background. Experimental data …

Background. Myocardial revascularization in diabetic patients is challenging with no
established optimum treatment strategy. We reviewed our coronary artery bypass grafting …

Objectives: This study compared survival after percutaneous coronary intervention (PCI) with
survival after coronary artery bypass graft surgery (CABG) among diabetics in the Veterans …

Twenty years have passed since the beginning of clinical interventional cardiology on the
occasion of the first angioplasty procedure performed by Andreas Gruentzig. This discipline …

The benefit of internal mammary artery (IMA) grafting as a long‐lasting intervention for
coronary artery disease is well recognized. However, largely because they are less invasive …

OBJECTIVES.: The purpose of this study was to report the 3-year follow-up results of the
ERACI trial (Argentine Randomized Trial of Percutaneous Transluminal Coronary …

Objective.—To examine differences in outcomes and patient management between patients
in the United States and outside the United States undergoing thrombolysis for acute …

Aims Long-term benefit from coronary revascularization with drug-eluting stents (DES)
relative to bare metal stents (BMS) and coronary artery bypass grafting (CABG) has not been …